BPG is committed to discovery and dissemination of knowledge
Featured Articles
9/22/2014 8:04:00 AM | Browse: 736 | Download: 1105
 |
Received |
|
2013-12-29 15:16 |
 |
Peer-Review Started |
|
2013-12-29 20:15 |
 |
To Make the First Decision |
|
2014-02-27 10:53 |
 |
Return for Revision |
|
2014-03-04 20:56 |
 |
Revised |
|
2014-03-12 10:24 |
 |
Second Decision |
|
2014-05-19 09:05 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2014-05-19 09:19 |
 |
Articles in Press |
|
2014-05-23 12:25 |
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2014-09-03 17:47 |
 |
Publish the Manuscript Online |
|
2014-09-19 20:46 |
Category |
Genetics & Heredity |
Manuscript Type |
Review |
Article Title |
Genome engineering using the CRISPR/Cas system
|
Manuscript Source |
Invited Manuscript |
All Author List |
Takuro Horii and Izuho Hatada |
Funding Agency and Grant Number |
Funding Agency |
Grant Number |
Ministry of Education, Culture, Sports, Science and Technology of Japan |
|
Ministry of Health, Labour and Welfare of Japan |
|
ational Institute of Biomedical Innovation |
|
Asahi Glass Foundation |
|
Ichiro Kanehara Foundation |
|
Program for Cultivating Global Leaders in Heavy Ion Therapeutics and Engineering |
|
|
Corresponding Author |
Izuho Hatada, PhD, Laboratory of Genome Science, Biosignal Genome Resource Center, Institute for Molecular and Cellular Regulation, Gunma University, 3-39-15 Showa-machi, Maebashi, Gunma 371-8512,
Japan. hatada@gunma-u.ac.jp
|
Key Words |
Clustered regularly at interspaced short palindromic repeats; Clustered regularly at interspaced short palindromic repeats associated 9; Genome engineering; Double-strand breaks; Non-homologous end joining; Homology-directed repair |
Core Tip |
This review introduces the latest information about the genome manipulation technology of the clustered regularly at interspaced short palindromic repeats (CRISPR)/CRISPR associated (Cas) system to readers. We focus particularly on the application of CRISPR/Cas in mammalian cultured cells and mice. The problems of off-target effects and the prospects for therapeutic applications of CRISPR/Cas in the future are also discussed.
|
Publish Date |
2014-09-19 20:46 |
Citation |
Horii T, Hatada I. Genome engineering using the CRISPR/Cas system. World J Med Genet 2014; 4(3): 69-76 |
URL |
http://www.wjgnet.com/2220-3184/full/v4/i3/69.htm |
DOI |
http://dx.doi.org/10.5496/wjmg.v4.i3.69 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345